Form 4: Neuronetics Director Cascella Increases Stake with $200K+ Share Purchase
SEC Form 4 Filing
Director Robert Cascella increases his holdings in Neuronetics, Inc. (STIM) with a purchase of 88,888 shares at $2.25 per share.
Summary
- On February 7, 2025, Director Robert Cascella purchased 88,888 shares of Neuronetics, Inc. common stock.
- The purchase price was $2.25 per share.
- This transaction increased Cascella's direct holdings to 541,986 shares.
Sentiment
Score: 7
Explanation: Director's purchase indicates confidence, but the document is purely transactional.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. Director purchases are often viewed positively by investors.
Stakeholder Impact
- The increased stake of a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of the transaction: Robert Cascella purchased 88,888 shares of Neuronetics, Inc. |
| 02/10/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.